Related Experiment Video
Updated: Mar 27, 2026

High-throughput Quantitative Real-time RT-PCR Assay for Determining Expression Profiles of Types I and III Interferon Subtypes
Published on: March 24, 2015
Cumulative False-Positive QuantiFERON-TB Interferon-γ Release Assay Results
Thomas E Gamsky1,2, Thomas Lum3, Melody Hung-Fan4
11 Contra Costa County Employee Occupational Medicine Clinic, Department of Health Services, Division of Public Health, Martinez, California.
The QuantiFERON-TB assay shows poor reproducibility and accuracy for latent tuberculosis screening. Frequent, sporadic positive results suggest discontinuing its use in low-risk populations.
Area of Science:
- Medical Diagnostics
- Infectious Disease Research
- Public Health Screening
Background:
- The QuantiFERON-TB (interferon-gamma release assay) is increasingly used for latent tuberculosis screening despite concerns about reliability.
- Evidence regarding its reproducibility and accuracy in serial testing is needed.
Purpose of the Study:
- To evaluate the reproducibility of the QuantiFERON-TB assay in annual screening.
- To assess the accumulation of false-positive results with repeated annual testing.
- To examine the validity of confirming positive results with a second QuantiFERON-TB test.
Main Methods:
- Retrospective, longitudinal evaluation of serial screening results from 2001 to 2013.
- Review of QuantiFERON-TB and tuberculin test results in a cohort of emergency responders.
- Analysis of test results over a maximum of 7 years of annual examinations.
Main Results:
- Positive QuantiFERON-TB results occurred sporadically in new individuals each year.
- Only 10 of 80 initially positive individuals remained positive the following year; 9 became negative within 3 years.
- After 7 years, 27.4% of the cohort had a positive result, indicating cumulative, irreproducible positives.
Conclusions:
- Frequent, cumulative, sporadic, and irreproducible positive results were observed.
- Findings support discontinuing the QuantiFERON-TB assay for latent tuberculosis diagnosis in low-risk populations.
- The assay's performance in serial screening raises significant concerns about its diagnostic utility.
More Related Videos
06:03Author Spotlight: Advancing Immune Monitoring in Critical Care Patients Using Whole Blood Assays
Published on: September 20, 2024
08:26Development and Validation of an Ultrasensitive Single Molecule Array Digital Enzyme-linked Immunosorbent Assay for Human Interferon-α
Published on: June 14, 2018